Taxanes in the elderly patient with metastatic breast cancer [Corrigendum]
Yardley DA. Breast Cancer Targets Therapy. 2015:7;293–301.On page 300, Disclosure section, “The author reports no conflicts of interest in the work” has been updated since publication and should read “Dr Yardley reports nonfinancial support from Celgene pertai...
Saved in:
Main Author: | Yardley DA |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/b58e87eb8d3547e6b2991eacd2d9bdeb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Taxanes in the elderly patient with metastatic breast cancer
by: Yardley DA
Published: (2015) -
A Retrospective Analysis of the Effect of Irinotecan-Based Regimens in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
by: Jiaojiao Suo, et al.
Published: (2021) -
Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study
by: Linda T. Vahdat, et al.
Published: (2021) -
Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients
by: Sawaki M
Published: (2014) -
Comprehensive characterization of distinct genetic alterations in metastatic breast cancer across various metastatic sites
by: Soojin Cha, et al.
Published: (2021)